Table 5 Summary of Significant Regression Line Positive Slopes by Cancer, Substance and P-Value Calculations Utilize Logarithm of Rates of Cannabis and Cannabinoid Exposure

1

Prostate

4.68E-19

6.73E-26

4.86E-04

1.15E-44

2

Ovary

2.50E-14

3.40E-16

1.52E-04

2.53E-09

7.61E-36

3

Bladder

4.78E-05

2.65E-14

1.66E-06

1.27E-11

2.77E-29

1.70E-10

2.02E-05

4

Colorectal

1.60E-95

1.50E-14

4.96E-23

5

All_Cancer

6.10E-30

2.48E-02

1.69E-19

6

Hodgkins

1.08E-02

1.87E-06

3.37E-02

2.20E-12

7

Lung

5.75E-119

1.15E-03

1.31E-10

8

Brain

1.84E-05

1.04E-08

9

NH_Lymphoma

2.25E-04

1.05E-08

10

Esophagus

2.75E-02

8.06E-05

3.68E-08

11

Stomach

2.43E-12

3.05E-04

12

Breast

2.09E-07

1.07E-15

1.09E-11

3.03E-03

1.68E-14

7.57E-11

1.94E-14

13

Liver

2.15E-27

9.68E-54

3.08E-28

4.67E-56

7.57E-40

14

Thyroid

9.25E-30

1.16E-52

1.29E-31

3.86E-52

6.51E-37

15

Pancreas

5.58E-09

1.60E-22

2.03E-09

1.54E-23

1.49E-15

16

AML

2.22E-07

4.73E-22

3.32E-08

8.47E-24

3.05E-12

17

Oropharynx

4.82E-05

1.14E-08

5.82E-10

4.08E-04

18

Kidney

6.19E-09

2.84E-05

3.38E-06

19

Melanoma

4.15E-03

3.47E-03

2.14E-03

1.91E-02

20

Cervix

5.88E-38

2.41E-06

21

Vulva.&.Vagina

6.79E-18

22

Penis

6.90E-06

23

Kaposi

8.98E-04

24

CLL

1.78E-06

Cancer Numbers

14

9

3

8

6

8

12

6

8

8